HESA - Follow-up analysis to "Federal Cost of a National Pharmacare Program"

During PBO's apprearance before the Committee 17 October 2017, the Committee requested additional analysis of the $3.9 billion spent on drugs not listed on Quebec's formulary. 

Follow-up Analysis to Costing Analysis of a National Pharmacare Program

Related posts